In this issue:
Comparative safety of DOACs and warfarin in VTE
Incidence and outcomes of acquired aplastic anaemia
Characterisation of AF events reported with ibrutinib
Prothrombin complex concentrates for DOAC-associated major bleeds
Iron chelation therapy increases OS in low-risk MDS
JAK2 inhibitor, NS-018, in myelofibrosis
DRC for Waldenström’s macroglobulinaemia
CLL treated with CD19-specific CAR-T-cells after ibrutinib failure
Restrictive vs. liberal transfusion strategies in older adults
All-trans retinoic acid + danazol: second-line for primary immune thrombocytopenia
Please login below to download this issue (PDF)